Stockreport

Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge

BioPlus Acquisition Corp.  (BIOS) 
Last bioplus acquisition corp. earnings: 11/6 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: bioscrip.com/investors
PDF Creates a Leading Independent Provider of Home and Alternate Site Infusion Services with Deep Clinical Expertise and Broad Therapy Portfolio [Read more]